T0	STARTING_MATERIAL 400 463	3-piperidin-4-yl-1,3,4,5-tetrahydro-benzo[d][1,3]diazepin-2-one
T1	YIELD_PERCENT 557 560	35%
T2	REACTION_PRODUCT 193 196	108
T9	REACTION_STEP 225 233	starting
T3	YIELD_OTHER 549 555	250 mg
T4	REACTION_PRODUCT 565 740	5-(2-chloro-3-methoxyphenyl)-3-((S)-2-methoxy-1-methylethyl)-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione
T10	REACTION_STEP 744 752	obtained
T5	STARTING_MATERIAL 260 374	[5-(2-chloro-3-methoxyphenyl)-3-((S)-2-methoxy-1-methylethyl)-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl]-acetic acid
T6	OTHER_COMPOUND 534 547	ethyl acetate
T11	WORKUP 515 530	crystallization
T7	REACTION_PRODUCT 7 182	5-(2-chloro-3-methoxyphenyl)-3-((S)-2-methoxy-1-methylethyl)-1-{2-oxo-2-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-ethyl}-1H-pyrimidine-2,4-dione
T8	EXAMPLE_LABEL 0 5	108.2
R0	ARG1 Arg1:T9 Arg2:T5
R1	ARG1 Arg1:T9 Arg2:T0
R2	ARGM Arg1:T10 Arg2:T3
R3	ARGM Arg1:T10 Arg2:T1
R4	ARG1 Arg1:T10 Arg2:T4
R5	ARG1 Arg1:T11 Arg2:T6
